Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts
Author:
Corresponding Author:

Je Hyun Seo. Department of Ophthalmology, Pusan National University Yangsan Hospital, 20 Geuo-ro, Mulgum, Yangsan 50612, Korea. jazmin2@naver.com

Affiliation:

Clc Number:

Fund Project:

Supported by the Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Korea (No.30-2013-009).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To investigate the toxicity of the E-prostanoid 2 (EP2) receptor agonist, butaprost against human subconjunctival (Tenon’s capsule) fibroblasts, and to determine the underlying mechanism. METHODS: We isolated Tenon’s fibroblasts from the subconjunctival area of healthy subjects and evaluated the types of EP receptors expressed using quantitative real-time reverse transcription polymerase chain reaction (RT-PCR). The toxicity of butaprost against the fibroblasts was evaluated using methyl thiazolyl tetrazolium and lactic dehydrogenase assays. The inhibition of conjunctival fibroblast proliferation by butaprost was assessed by measuring α-actin levels. The underlying mechanism was assessed by measuring intracellular cyclic adenosine monophosphate (cAMP) levels. Intergroup differences were statistically analyzed using an independent t-test. Densitometry of the Western blot bands was performed using the Image J software. RESULTS: Quantitative real-time RT-PCR revealed that the fibroblast EP2 receptor levels were higher than those of the other EP receptors. Butaprost did not show toxicity against Tenon’s tissue, but inhibited conjunctival fibroblast proliferation by reducing collagen synthesis. EP2 receptor activation enhanced the cAMP cascade, which might be an important mechanism underlying this effect. CONCLUSION: Butaprost effectively reduces the subconjunctival scarring response. Given the significance of wound healing modulation in blebs, butaprost’s inhibitory effect on subconjunctival Tenon’s fibroblasts may be beneficial in managing postoperative scarring in glaucoma surgery.

    Reference
    Related
    Cited by
Get Citation

Jong Hoon Shin, Je Hyun Seo, Jae Ho Jung, et al. Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts. Int J Ophthalmol, 2017,10(7):1028-1033

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:June 01,2016
  • Revised:April 14,2017
  • Adopted:
  • Online: July 11,2017
  • Published: